Patents by Inventor Grigorios Fotopoulos

Grigorios Fotopoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Moderating the effect of endotoxins
    Patent number: 8216605
    Abstract: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: July 10, 2012
    Assignee: Nestec S.A.
    Inventors: Irène Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli
  • MODERATING THE EFFECT OF ENDOTOXINS
    Publication number: 20100028316
    Abstract: The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
    Type: Application
    Filed: June 12, 2009
    Publication date: February 4, 2010
    Applicant: Nestec S.A.
    Inventors: Irène Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli
  • Moderating the effect of endotoxins
    Publication number: 20070122453
    Abstract: The present invention relates to the use of an oral composition comprising meat extract and peptones, separately or in combination, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
    Type: Application
    Filed: October 12, 2004
    Publication date: May 31, 2007
    Applicant: Nestec S.A.
    Inventors: Irene Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli
  • Moderating the effect of endotoxins
    Publication number: 20060292171
    Abstract: The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.
    Type: Application
    Filed: October 13, 2004
    Publication date: December 28, 2006
    Applicant: NESTEC S.A.
    Inventors: Irene Corthesy-Theulaz, Grigorios Fotopoulos, Gabriela Bergonzelli